These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 9394783

  • 1. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE.
    Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD.
    J Neuroimmunol; 1997 Nov; 79(2):113-8. PubMed ID: 9394783
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
    Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD.
    Immunol Rev; 1998 Aug; 164():63-72. PubMed ID: 9795764
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis.
    Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD.
    J Neuroimmunol; 2000 Sep 22; 109(2):173-80. PubMed ID: 10996219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL, Dal Canto MC, Bluestone JA, Miller SD.
    J Virol; 2000 Sep 22; 74(18):8349-57. PubMed ID: 10954534
    [Abstract] [Full Text] [Related]

  • 12. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M, Yagita H, Sayegh MH, Khoury SJ.
    J Immunol; 2006 Mar 15; 176(6):3480-9. PubMed ID: 16517716
    [Abstract] [Full Text] [Related]

  • 13. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis.
    Karandikar NJ, Vanderlugt CL, Eagar T, Tan L, Bluestone JA, Miller SD.
    J Immunol; 1998 Jul 01; 161(1):192-9. PubMed ID: 9647224
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
    Karpus WJ, Kennedy KJ, Smith WS, Miller SD.
    J Neurosci Res; 1996 Aug 15; 45(4):410-23. PubMed ID: 8872901
    [Abstract] [Full Text] [Related]

  • 15. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
    Bell JJ, Min B, Gregg RK, Lee HH, Zaghouani H.
    J Immunol; 2003 Aug 15; 171(4):1801-8. PubMed ID: 12902480
    [Abstract] [Full Text] [Related]

  • 16. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
    Jones RE, Bourdette D, Moes N, Vandenbark A, Zamora A, Offner H.
    J Immunol; 2003 Feb 15; 170(4):1690-8. PubMed ID: 12574332
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD.
    Blood; 2003 Dec 15; 102(13):4464-71. PubMed ID: 12933585
    [Abstract] [Full Text] [Related]

  • 18. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
    Voskuhl RR, Farris RW, Nagasato K, McFarland HF, Dalcq MD.
    J Neuroimmunol; 1996 Nov 15; 70(2):103-11. PubMed ID: 8898718
    [Abstract] [Full Text] [Related]

  • 19. CTLA-4: a negative regulator of autoimmune disease.
    Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA.
    J Exp Med; 1996 Aug 01; 184(2):783-8. PubMed ID: 8760834
    [Abstract] [Full Text] [Related]

  • 20. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen.
    Whitham RH, Wingett D, Wineman J, Mass M, Wegmann K, Vandenbark A, Offner H.
    J Neurosci Res; 1996 Jul 15; 45(2):104-16. PubMed ID: 8843028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.